550
Participants
Start Date
September 30, 2005
Study Completion Date
December 31, 2006
Budesonide/formoterol
Symbicort® Turbohaler®
Research Site, Fowey
Research Site, Hove
Research Site, Ilford
Research Site, Glenrothes
Research Site, Dartford
Research Site, Airdrie
Research Site, Hamilton
Research Site, Doncaster
Research Site, Cookstown
Research Site, Downpatrick
Research Site, Barry
Research Site, Chase Terrace
Research Site, East Horsley
Research Site, Crawley
Research Site, Box
Research Site, Bradford-on-Avon
Research Site, Ashford
Research Site, Atherstone
Research Site, Ayrshire
Research Site, Bath
Research Site, Blackpool
Research Site, Bolton
Research Site, Cardiff
Research Site, Carrickfergus
Research Site, Cheshire
Research Site, Chesterfield
Research Site, Coventry
Research Site, Dundee
Research Site, Ellesmere Port
Research Site, Fife
Research Site, Glasgow
Research Site, Harrow
Research Site, Larne
Research Site, Leeds
Research Site, Middlesbrough
Research Site, Newcastle
Research Site, Newtownabbey
Research Site, Peterhead
Research Site, Pontypridd
Research Site, Reading
Research Site, Rugby
Research Site, Rutherglen
Research Site, Sandy
Research Site, Sheffield
Research Site, Stafford
Research Site, Stevenage
Research Site, Stockport
Research Site, Sunbury-on-Thames
Research Site, Sutton Coldfield
Research Site, Tilehurst
Research Site, Tonbridge
Research Site, Trowbridge
Research Site, Vale of Glamorgan
Research Site, Warminster
Research Site, Watford
Research Site, Wells-next-the-Sea
Research Site, Westbury
Research Site, Woking
Research Site, Yaxley
Lead Sponsor
AstraZeneca
INDUSTRY